Author Topic: (Abst.) Smell as a clinical marker for functional limitations in MS  (Read 43 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
From PubMed (October 6, 2020)--"Smell as a clinical marker for functional limitations in multiple sclerosis":




https://pubmed.ncbi.nlm.nih.gov/33011622/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
103 Views
Last post September 12, 2016, 06:46:10 pm
by agate
0 Replies
102 Views
Last post December 13, 2016, 07:26:06 am
by agate
0 Replies
79 Views
Last post June 29, 2018, 02:39:18 pm
by agate
0 Replies
75 Views
Last post February 01, 2019, 09:34:22 pm
by agate
0 Replies
42 Views
Last post November 29, 2019, 08:50:17 pm
by agate